Literature DB >> 11136791

Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agar.

A Al Mosaid1, D Sullivan, I F Salkin, D Shanley, D C Coleman.   

Abstract

The methods currently available for the identification of the pathogenic yeast Candida dubliniensis all have disadvantages in that they are time-consuming, expensive, and/or, in some cases, unreliable. In a recent study (P. Staib and J. Morschhäuser, Mycoses 42:521-524; 1999) of 14 C. dubliniensis and 11 C. albicans isolates, it was suggested that the ability of C. dubliniensis to produce rough colonies and chlamydospores (chlamydoconidia) on Staib agar (SA) provided a simple means of differentiating it from its close relative C. albicans. In the present investigation, we examined the colony morphology and chlamydospore production of 130 C. dubliniensis and 166 C. albicans isolates on SA and on the related defined medium caffeic acid-ferric citrate agar (CAF). All of the C. dubliniensis and C. albicans isolates produced chlamydospores on the control medium, i.e., rice-agar-Tween agar. However, while none of the C. albicans isolates produced chlamydospores on either SA or CAF, 85.4 and 83.8% of the C. dubliniensis isolates produced chlamydospores on SA and CAF, respectively. All of the C. albicans isolates grew as smooth, shiny colonies on SA after 48 to 72 h of incubation at 30 degrees C, while 97.7% of the C. dubliniensis isolates grew as rough colonies, many (65%) with a hyphal fringe. In contrast, 87.4% of the C. albicans and 93.8% of the C. dubliniensis isolates yielded rough colonies on CAF. Although the results of this study confirm that SA is a good medium for distinguishing between C. dubliniensis and C. albicans, we believe that discrimination between these two species is best achieved on the basis of colony morphology rather than chlamydospore production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136791      PMCID: PMC87722          DOI: 10.1128/JCM.39.1.323-327.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis.

Authors:  P Staib; J Morschhäuser
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

2.  Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel.

Authors:  I Polacheck; J Strahilevitz; D Sullivan; S Donnelly; I F Salkin; D C Coleman
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  The brown colour effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of C. neoformans infections in AIDS patients.

Authors:  F Staib; M Seibold; E Antweiler; B Fröhlich; S Weber; A Blisse
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1987-08

4.  Isolation of C. dubliniensis from insulin-using diabetes mellitus patients.

Authors:  A M Willis; W A Coulter; D J Sullivan; D C Coleman; J R Hayes; P M Bell; P J Lamey
Journal:  J Oral Pathol Med       Date:  2000-02       Impact factor: 4.253

5.  Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users.

Authors:  P Boerlin; F Boerlin-Petzold; C Durussel; M Addo; J L Pagani; J P Chave; J Bille
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

6.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

7.  Caffeic acid-containing medium for identification of Cryptococcus neoformans.

Authors:  R L Hopfer; F Blank
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

8.  Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation.

Authors:  P J Gallagher; D E Bennett; M C Henman; R J Russell; S R Flint; D B Shanley; D C Coleman
Journal:  J Gen Microbiol       Date:  1992-09

9.  Pigment production of Cryptococcus neoformans grown with extracts of Guizotia abyssinica.

Authors:  A A Strachan; R J Yu; F Blank
Journal:  Appl Microbiol       Date:  1971-09

10.  Candida dubliniensis fungemia: the first four cases in North America.

Authors:  M E Brandt; L H Harrison; M Pass; A N Sofair; S Huie; R K Li; C J Morrison; D W Warnock; R A Hajjeh
Journal:  Emerg Infect Dis       Date:  2000 Jan-Feb       Impact factor: 6.883

View more
  23 in total

1.  Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies.

Authors:  Agnes Marot-Leblond; Bertrand Beucher; Sandrine David; Sandrine Nail-Billaud; Raymond Robert
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.

Authors:  Sarah F Gee; Sophie Joly; David R Soll; Jacques F G M Meis; Paul E Verweij; Itzhack Polacheck; Derek J Sullivan; David C Coleman
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting.

Authors:  Asmaa Al Mosaid; Derek J Sullivan; Itzhack Polacheck; Faisal A Shaheen; Osama Soliman; Saleh Al Hedaithy; Sahar Al Thawad; Motaz Kabadaya; David C Coleman
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans.

Authors:  Christian O Mosca; María D Moragues; José Llovo; Asmaa Al Mosaid; David C Coleman; José Pontón
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes.

Authors:  K Oliveira; G Haase; C Kurtzman; J J Hyldig-Nielsen; H Stender
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

6.  Racial distribution of Candida dubliniensis colonization among South Africans.

Authors:  Elaine Blignaut; Claude Pujol; Sophie Joly; David R Soll
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  Candida dubliniensis at a university hospital in Saudi Arabia.

Authors:  R Fotedar; S S A Al-Hedaithy
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Epidemiology and antifungal susceptibility of bloodstream Candida isolates in Quebec: Report on 453 cases between 2003 and 2005.

Authors:  Guy St-Germain; Michel Laverdière; René Pelletier; Pierre René; Anne-Marie Bourgault; Claude Lemieux; Michael Libman
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

9.  A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.

Authors:  Brenda A McManus; Gary P Moran; Judy A Higgins; Derek J Sullivan; David C Coleman
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

10.  Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans.

Authors:  Zia U Khan; Suhail Ahmad; Eiman Mokaddas; Rachel Chandy
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.